Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation.
Fuji S, Tokunaga M, Kato K, Nakano N, Shindo T, Makiyama J, Itonaga H, Ito A, Eto T, Ishikawa J, Hasegawa Y, Ishitsuka K, Moriuchi Y, Ota S, Mori Y, Suehiro Y, Takase K, Kanda Y, Onizuka M, Fukuda T, Atsuta Y, Yoshimitsu M.
Fuji S, et al.
Bone Marrow Transplant. 2025 Feb 3. doi: 10.1038/s41409-025-02517-1. Online ahead of print.
Bone Marrow Transplant. 2025.
PMID: 39901032
No abstract available.